Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
0.008
%
2,61%
Latest
0.314
High
0.314
Low
0.3
Volume
21 350
Turnover (SEK)
6 634
Market Value (MSEK)
18,0
Time (Latest trade)

Board

CEO

  • Fredrik Jonsson

Chairperson of the Board

  • Anders Althin

Board

  • Charlotte Althin Hicks
  • Fredrik Jonsson
  • Mats Wahlström